ArticleThe oncologist2015
Should FOLFOXIRI plus bevacizumab Be the standard first-line therapy in metastatic colorectal cancer?
Ryan D Nipp et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleThe oncologist2015
Ryan D Nipp et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.